|
Sign In to gain access to subscriptions and/or personal tools.
|
Thrombosed Central Venous Catheters: Restoring Function With 6-Hour Urokinase Infusion After Failure of Bolus Urokinase
William D. Haire, MD
Department of Internal Medicine, University of Nebraska Medical Center, Omaha
Robert P. Lieberman, MD
Department of Radiology, University of Nebraska Medical Center, Omaha
Nineteen central venous catheters with radio-graphically proven thrombotic occlusion failed to have function restored with a mean of 1.6 5000-unit boluses of urokinase per catheter. Catheters then underwent a 6-hour infusion of urokinase at 40,000 units per hour followed by repeat contrast injection and evaluation of function. Reduction in thrombus size occurred in all but one patient. Catheter function was restored in 15 patients. In two patients, thrombus dissolved but catheters remained occluded because of tip malposition. In the remaining two patients, catheter function was restored with an additional 6-hour infusion. No adverse reactions to the infusion were seen. After infusion catheters continued to function normally for a mean of 36.2 days. Five catheters rethrombosed, two of which responded to urokinase bolus instillation. Thrombosed catheters failing standard intracatheter bolus urokinase are generally salvaged with a 6-hour infusion of low-dose urokinase.(Journal of Parenteral and Enteral Nutrition 16:129-132, 1992)
Journal of Parenteral and Enteral Nutrition, Vol. 16, No. 2,
129-132 (1992)
DOI: 10.1177/0148607192016002129

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Galloway and A. Bodenham
Long-term central venous access
Br. J. Anaesth.,
May 1, 2004;
92(5):
722 - 734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Verso and G. Agnelli
Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients
J. Clin. Oncol.,
October 1, 2003;
21(19):
3665 - 3675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. D. Haire and S. L. Herbst
Invited Review: Use of Alteplase (t-PA) for the Management of Thrombotic Catheter Dysfunction: Guidelines From a Consensus Conference of the National Association of Vascular Access Networks (NAVAN)
Nutr Clin Pract,
December 1, 2000;
15(6):
265 - 275.
[PDF]
|
 |
|

|
 |

|
 |
 
J. Schindler, R. D. Bona, H. H. Chen, J. M. Feingold, R. L. Edwards, P. J. Tutschka, and S. Bilgrami
Regional Thrombolysis with Urokinase for Central Venous Catheter-related Thrombosis in Patients Undergoing High-dose Chemotherapy with Autologous Blood Stem Cell Rescue
Clinical and Applied Thrombosis/Hemostasis,
January 1, 1999;
5(1):
25 - 29.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Stephens, W. D. Haire, and G. D. Kotulak
Are Clinical Signs Accurate Indicators of the Cause of Central Venous Catheter Occlusion?
JPEN J Parenter Enteral Nutr,
January 1, 1995;
19(1):
75 - 79.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Krzywda, D. A. Andris, and E. J. Quebbeman
Urokinase Infusion for Thrombosed Catheters
JPEN J Parenter Enteral Nutr,
November 1, 1992;
16(6):
596 - 596.
[PDF]
|
 |
|
|
|